Sector: Pharmaceuticals & Biotechnology

Small Cap

Mono Pharmacare Share Price

Q: What is the Market Capitalization of Mono Pharmacare Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Mono Pharmacare Ltd. is approximately ₹ 18.6 Cr.

Q: What are the PE and PB ratios for Mono Pharmacare Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Mono Pharmacare Ltd. is 6, and the Price-to-Book (PB) ratio is 0.6.

Q: What is the 52-Week High and Low for Mono Pharmacare Ltd.?

Over the past 52 weeks, the highest price reached by Mono Pharmacare Ltd. shares was ₹ 27.5, and the lowest price was ₹ 9.45.

Q: Who are the major shareholders of Mono Pharmacare Ltd.?

Significant shareholdings in Mono Pharmacare Ltd. typically include entities such as: Promoter Public Other Institutions (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of Mono Pharmacare Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Mono Pharmacare Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

MONOPHARMA

₹10.50

0.00(0.00%)

NSE : MONOPHARMA

Open Free Demat Account

Mono Pharmacare Performance

Price Movement

₹10.50

↘ Today's Low↗ Today's High

1 Year Performance

₹10.50

₹9.45

₹27.50

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹10.50

Low₹10.50

Open at₹10.50

Prev Close₹10.50

Volumes2.00 K

Avg Price₹10.50

Lower Circuit₹10.00

Upper Circuit₹11.00

Historical Performance

3M High₹13.25

3M Low₹10.25

1 Yr High₹27.50

1 Yr Low₹9.45

3 Yr High₹75.00

3 Yr Low₹9.45

5 Yr High₹75.00

5 Yr Low₹9.45

Summary

As of 24-07-2026 10:36, Mono Pharmacare Ltd. share price today is ₹0, with a change of ₹-10.50 (-100.00%) from the previous close of ₹10.5. The stock opened at ₹10.5 and traded between ₹10.5 and ₹10.5, with a total traded volume of 2000 shares. The company has a market capitalization of ₹18.6 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹27.5 and ₹9.45, respectively.

Mono Pharmacare Ltd. valuation metrics include a P/E ratio of 6, EPS of ₹1.75, and book value of ₹0.60. Profitability indicators show ROE of 9.95%.

Mono Pharmacare Ltd. technical indicators include Day RSI at 42.05, Day MFI at 44.55, Day ADX at 22.15. Additional indicators include Commodity Channel Index (CCI) at -106.5 and Williams %R at -73.68. Momentum indicators show Day MACD at -0.3, Day MACD Signal Line at -0.29, DayATR at 0.35. Rate of Change indicators for Mono Pharmacare Ltd. include ROC125 at -50 and ROC21 at -6.67.

Exponential moving averages include EMA5 at ₹10.6, EMA10 at ₹10.7, EMA12 at ₹10.7, EMA20 at ₹10.9, EMA26 at ₹11, EMA50 at ₹11.5, EMA100 at ₹13.2, EMA200 at ₹17.4. Simple moving averages include SMA5 at ₹10.5, SMA10 at ₹10.7, SMA20 at ₹10.9, SMA30 at ₹11.1, SMA50 at ₹11.7, SMA100 at ₹12, SMA150 at ₹15.2, SMA200 at ₹17.6.

Support levels for Mono Pharmacare are placed at First Support ₹10.50, Second Support ₹10.50, Third Support ₹10.50. Resistance levels are seen at First Resistance ₹10.50, Second Resistance ₹10.50, Third Resistance ₹10.50. Mono Pharmacare Ltd. shareholding pattern shows promoter holding at 56.72%, FII holding at 0%, DII holding at 0%, public holding at 43.27%.

Mono Pharmacare Fundamentals

Market Cap

Low in industry

18.60 Cr.

PE Ratio (TTM)

Low in industry

Dividend Yield

Net Profit TTM

Net profit TTM

Net Profit Growth

Net profit TTM

PEG Ratio

ROE

13.8% incr over last year

9.95

Operating Revenue TTM

Operating Revenue Growth

Operating Revenue TTM

Book Value

Low in industry

0.60

MFI

MFI is mid-range

44.55

RSI

RSI is mid-range

42.05

EPS (TTM)

1.75

Debt to Equity

1.72

Face Value

Operating Profit Margin Qtr.

4.51

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

0.60

Mono Pharmacare Financials

Data not available for chart

Indicator
No Record Found

Mono Pharmacare Technicals

Mono Pharmacare Ltd. EMA & SMA

₹10.50

0.10 (0.96%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹10.6

Day EMA10 ₹10.7

Day EMA12 ₹10.7

Day EMA20 ₹10.9

Day EMA26 ₹11

Day EMA50 ₹11.5

Day EMA100 ₹13.2

Day EMA200 ₹17.4

Mono Pharmacare Support and Resistance

Resistance

First Resistance₹10.50

Second Resistance₹10.50

Third Resistance₹10.50

Support

First Support₹10.50

Second Support₹10.50

Third Support₹10.50

Technical Indicators

Day RSI42.05

Day MFI44.55

Day ADX22.15

Day Commodity Channel Index-106.50

William-73.68

Day MACD-0.30

Day MACD Signal Line-0.29

Day ATR0.35

Day ROC125-50.00

Day ROC21-6.67

Mono Pharmacare Shareholding Pattern

Held By	Mar 2025	Sep 2025	Mar 2026
Promoter	56.7	56.7	56.7
FII	0	0	0
DII	0	0	0
Public	43.3	43.3	43.3

Mono Pharmacare Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	2 K	2 K	100.00%
Week	2.67 K	3.33 K	80.00%
1 Month	3.87 K	5.33 K	72.50%
6 Month	10.94 K	12.45 K	87.92%

Mono Pharmacare SWOT Analysis

Strengths11

Weakness9

Opportunity0

Threats0

Rising Net Cash Flow and Cash from Operating activity

Annual Profit Growth higher than Sector Profit Growth

Relative Outperformance versus Industry over 1 Week

Effectively using its capital to generate profit - RoCE improving in last 2 years

Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Stock with Low PE (PE < = 10)

Top Gainers

Mono Pharmacare Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

Mono Pharmacare Stock Comparison

Financials	Bio Medica Laboratories Ltd.	Sai Parenterals Ltd.	Vivimed Labs Ltd.	Curis Lifesciences Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.
Price (₹)	₹138.80	₹539.10	₹5.25	₹112	₹163	₹15.10
% Change	-0.11%	-0.11%	1.55%	1.82%	-1.81%	0.13%
Revenue TTM (₹ Cr)	-	-	₹69.99	-	₹287.68	₹176.50
Net Profit TTM (₹ Cr)	-	-	₹-176.47	-	₹14.88	₹27.81
PE TTM	66.40	-	-0.20	12.90	43.30	28.80
1 Year Return	-0.04	37.68	417	-14.06	31.75	65.71
ROCE	-	3.56	-56.37	-	-	17.36

Similar Stocks

MEDISTEP

Medistep Healthcare Ltd.

₹ 19.75

-1.25%

INFLUX

Influx Healthtech Ltd.

₹ 290.10

-0.31%

MEDIORG

Medicamen Organics Ltd.

₹ 24.70

-5.00%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 506.00

-2.65%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 61.75

-0.82%

SIGACHI

Sigachi Industries Ltd.

₹ 25.50

-2.00%

WINDLAS

Windlas Biotech Ltd.

₹ 856.00

-0.63%

VINEETLAB

Vineet Laboratories Ltd.

₹ 38.60

+3.21%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 495.00

-5.49%

ZIMLAB

Zim Laboratories Ltd.

₹ 120.40

+1.30%

MEDICO

Medico Remedies Ltd.

₹ 37.93

-0.94%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 183.41

+2.33%

LASA

Lasa Supergenerics Ltd.

₹ 6.97

-1.83%

ADVENZYMES

Advanced Enzyme Technologies Ltd.

₹ 317.55

+1.05%

BAJAJHCARE

Bajaj Healthcare Ltd.

₹ 325.00

+2.30%

ORTINGLOBE

Ortin Global Ltd.

₹ 14.70

-1.41%

BROOKS

Brooks Laboratories Ltd.

₹ 64.40

-2.39%

RPGLIFE

RPG Life Sciences Ltd.

₹ 2970.00

+2.33%

BAFNAPH

Bafna Pharmaceuticals Ltd.

₹ 238.15

-2.00%

ALPA

Alpa Laboratories Ltd.

₹ 66.33

-0.72%

SMSPHARMA

SMS Pharmaceuticals Ltd.

₹ 385.95

+0.34%

NECLIFE

Nectar Lifesciences Ltd.

₹ 10.30

-0.58%

MANGALAM

Mangalam Drugs and Organics Ltd.

₹ 27.10

-0.26%

INDOCO

Indoco Remedies Ltd.

₹ 243.00

+2.04%

FAQ's on MONOPHARMA

What is the Market Capitalization of Mono Pharmacare Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Mono Pharmacare Ltd. is approximately ₹ 18.6 Cr.

What are the PE and PB ratios for Mono Pharmacare Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Mono Pharmacare Ltd. is 6, and the Price-to-Book (PB) ratio is 0.6.

What is the 52-Week High and Low for Mono Pharmacare Ltd.?

Over the past 52 weeks, the highest price reached by Mono Pharmacare Ltd. shares was ₹ 27.5, and the lowest price was ₹ 9.45.

Who are the major shareholders of Mono Pharmacare Ltd.?

Significant shareholdings in Mono Pharmacare Ltd. typically include entities such as:

Promoter
Public
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Mono Pharmacare Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Mono Pharmacare Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy